<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma</article-title>
</title-group>
